Shu Ching Lin
Director/Board Member en UNITED BIOPHARMA INC .
Perfil
Shu Ching Lin is currently a Director at United BioPharma, Inc. and Shanghai Shen Lian Biomedical Corp.
She was formerly a Director at UBI Pharma Inc. She received her undergraduate and doctorate degrees from National Taiwan University.
Cargos activos de Shu Ching Lin
| Empresas | Cargo | Inicio |
|---|---|---|
| UNITED BIOPHARMA INC | Director/Board Member | 30/09/2013 |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Director/Board Member | - |
Antiguos cargos conocidos de Shu Ching Lin.
| Empresas | Cargo | Fin |
|---|---|---|
| UBI PHARMA INC. | Director/Board Member | - |
Formación de Shu Ching Lin.
| National Taiwan University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| UBI PHARMA INC. | Health Technology |
| SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Bolsa de valores
- Insiders
- Shu Ching Lin
